Related Experiment Video
Updated: Apr 25, 2026

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study
Mahyar Etminan1, James M Brophy2, Ali Samii2
1From the Department of Pediatrics (M.E.), Faculty of Medicine, University of British Columbia, Vancouver; Therapeutic Evaluation Unit (M.E.), Child & Family Research Institute of British Columbia, Vancouver; Department of Medicine, Epidemiology and Biostatistics (J.M.B.), McGill University, Montreal, Canada; and Department of Neurology (A.S.), University of Washington, Seattle. metminan@popi.ubc.ca metminan@shaw.ca.
Objective:
To quantify the risk of peripheral neuropathy (PN) with oral fluoroquinolone (FQ) use.
Methods:
We conducted a case-control study within a cohort of men aged 45 to 80 years in the United States followed from 2001 to 2011. Cases were defined as those with the first physician visit diagnosis of PN, polyneuropathy, or drug-induced polyneuropathy. Four controls were matched to each case by age, follow-up, and calendar time using density-based sampling. As a sensitivity analysis, we also quantified the risk of PN with finasteride use, a drug that is not expected to increase the risk of PN. Rate ratios (RRs) for current users of FQs were computed using conditional logistic regression, which was adjusted for chronic renal failure, chronic liver disease, hypothyroidism, postherpetic neuralgia, and the use of nitrofurantoin and metronidazole.
Results:
We identified 6,226 cases and 24,904 controls. Current users of FQs were at a higher risk of developing PN (RR = 1.83, 95% confidence interval [CI] 1.49-2.27). Current new users had the highest risk (RR = 2.07, 95% CI 1.56-2.74). No risk was observed for current users of finasteride (RR = 1.21, 95% CI 0.97-1.51).
Conclusions:
Current users, especially new users of FQs, are at a higher risk of developing PN. Despite the increase in the use of FQs, clinicians should weigh the benefits against the risk of adverse events when prescribing these drugs to their patients.
More Related Videos
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
10:55Fluorescence-quenching of a Liposomal-encapsulated Near-infrared Fluorophore as a Tool for In Vivo Optical Imaging
Published on: January 5, 2015
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Diabetic Neuropathy
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Drug Toxicity: Risk factors
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...